Skip to main content
Log in

Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Macrophages in the tissues have been shown to express receptor for urokinase-type plasminogen activator (uPAR) on their cell surface which plays an important role in cell invasion and attachment. We examined the effects of inflammatory mediators on the expression of uPAR employing U937 cells which have monocyte/ macrophage-like characteristics. U937 cells were incubated with various mediators such as interleukins (IL), tumor necrosis factors (TNF), dexamethasone, thrombin, fibrin fragment D, bradykinin, complement C5a, and components of the extracellular matrix. The uPAR expression on the cell surface was then analyzed by radio-ligand binding assay using125I-scuPA. The strongest enhancement of uPAR was observed in the cells stimulated by TNFα and TNFβ. IL-1β, IL-6, and C5a also increased the uPA binding sites with various patterns of affinity change. Dexamethasone decreased the uPA binding sites without changing the affinity. Fibrin fragment D and IL-3 reduced the affinity without changing the number of receptors. These findings suggest that the expression of uPAR in inflammatory cells could be modulated by various inflammatory mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Danø, K., A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L. S. Nielsen, andL. Skriver. 1985. Plasminogen activators, tissue degradation and cancer.Adv. Cancer Res. 44:139–266.

    Google Scholar 

  2. Ellis, V., N. Behrendt, andK. Danø. 1991. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.J. Biol. Chem. 266:12752–12758.

    Google Scholar 

  3. Ellis, V., C. Pyke, J. Eriksen, H. Solberg, andK. Danø. 1992. The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion.Ann. N.Y. Acad. Sci.667:13–31.

    Google Scholar 

  4. Schäfer, B. M., K. Maier, U. Eickhoff, R. F. Todd, andM. D. Kramer. 1994. Plasminogen activation in healing human wounds.Am. J. Pathol. 144:1269–1280.

    Google Scholar 

  5. Kirchheimer, J. C., Y-H. Nong, andH. G. Remold. 1988. IFN-γ, tumor necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes.J. Immunol. 141:4229–4234.

    Google Scholar 

  6. PicoNE, R., E. L. Kajtaniak, L. S. Nielsen, N. Behrendt, M. R. Mastronicola, M. V. Cubellis, M. P. Stoppelli, S. Pedersen, K. Danø, andF. Blasi. 1989. Regulation of Urokinase receptors in monocytelike U937 cells by phorbol ester myristate acetate.J. Cell Biol. 108:693–702.

    Google Scholar 

  7. Reuning, U., andN. U. Bang. 1992. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.Arterioscler. Thromb. 12:1161–1170.

    Google Scholar 

  8. Nielsen, L. S., G. M. Kellerman, N. Behrendt, R. Picone, K. Danø, andF. Blasi. 1988. A 55,000–60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.J. Biol. Chem. 263:2358–2363.

    Google Scholar 

  9. Conese, M., andF. Blasi. 1995. Urokinase/urokinase receptor system: Internalization/degradation of urokinase-serpin complexes: Mechanism and regulation.Biol. Chem. Hoppe-Seyler. 376:143–155.

    Google Scholar 

  10. Paulsson, M. 1992. Basement membrane proteins: Structure, assembly, and cellular interactions.Crit. Rev. Biochem. Mol. Biol. 27:93–127.

    Google Scholar 

  11. Pyke, C., P. Kristensen, E. Ralfkiaer, J. Grøndahl-Hansen, J. Eriksen, F. Blasi, andK. Danø. 1991. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.Am. J. Pathol. 138:1059–1067.

    Google Scholar 

  12. Behrendt, N., E. Rønne, M. Ploug, T. Petri, D. Løber, L. S. Nielsen, W-D. Schleuning, F. Blasi, E. Appella, andK. Danø. 1990. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.J. Biol. Chem. 265:6453–6460.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, E., Tsuchiya, K., Sugiki, M. et al. Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators. Inflammation 20, 319–326 (1996). https://doi.org/10.1007/BF01488206

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01488206

Keywords

Navigation